论文部分内容阅读
目的:探讨临床药师在面对心力衰竭合并低钠血症患者时应如何进行药学监护。方法:临床药师从低钠血症的形成机制、高危诱发因素等方面对低钠血症的用药进行分析和讨论,并实施药学监护。结果:在心力衰竭合并低钠血症患者的药学监护中,临床药师可通过合理使用利尿药,制订个体化限盐方案、补盐措施,监测并纠正低蛋白血症及低钾血症等方式,实现对低钠血症的有效防护及纠正。结论:应深入了解低钠血症的形成机制、危险诱发因素及预防措施,结合患者具体情况,开展个体化的低钠血症药学监护。
Objective: To investigate how clinical pharmacists should take care when faced with patients with heart failure and hyponatremia. Methods: The clinical pharmacists analyzed and discussed the treatment of hyponatremia in terms of the mechanism of hyponatremia and the risk-inducing factors, and implemented the pharmacy supervision. Results: In pharmacological care of patients with heart failure and hyponatremia, clinical pharmacists can make rational use of diuretics, formulate individualized salt restriction programs, salt supplementation measures, and monitor and correct hypoalbuminemia and hypokalemia , To achieve effective protection and correction of hyponatremia. Conclusion: The mechanism of hyponatremia, the predisposing factors and the preventive measures should be deeply understood. Combined with the specific conditions of patients, we should carry out personalized hyponatremia pharmacological care.